Considering that MAP is a combination of two components of BP: SBP and DBP, the proposed pathophysiologic mechanisms like insulin resistance, sympathetic nervous system activity, and arterial stiffness which are in regard to the relationship between increased BP and NAFLD [4] may serve as possible explanations that MAP independently increased the risk of incident NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.